Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Durvalumab
Related studies linked through entity extraction aliases.
Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Durvalumab in DLBCL After Autologous Transplant
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Study Of Durvalumab and Lenalidomide In R/R EBV Associated DLBCL Subtypes, Primary CNS And Testicular DLBCL
- Status
- WITHDRAWN
- Phase
- PHASE2
A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Durvalumab (Anti-PDL1) Plus Radiation Therapy for the Treatment of Solitary Bone Plasmacytoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety and Efficacy of MEDI0457 and Durvalumab in Participants With Human Papilloma Virus (HPV) Associated Recurrent/Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2